Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
58.90
+0.79 (1.36%)
Jun 27, 2025, 2:45 PM CST
41.31%
Market Cap 26.23B
Revenue (ttm) 2.42B
Net Income (ttm) 101.52M
Shares Out 445.34M
EPS (ttm) 0.21
PE Ratio 278.47
Forward PE 49.08
Dividend n/a
Ex-Dividend Date n/a
Volume 7,014,281
Average Volume 6,375,303
Open 57.14
Previous Close 58.11
Day's Range 57.14 - 60.90
52-Week Range 31.07 - 61.50
Beta 0.62
RSI 78.21
Earnings Date Aug 22, 2025

About Sinocelltech Group

Sinocelltech Group Limited, a biotech company, engages in the research and development, and industrialization of recombinant proteins, monoclonal antibodies, and innovative vaccines in China. The company offers Anpingxi an antibody drug and anti-tumor product; Anjiayin for the treatment of the rare disease hemophilia A; coronavirus 2-valent, a trimer protein vaccine; and mutant strain recombinant protein vaccines SCTV01C and SCTV01E. Its pipeline products include SCT630 used for the treatment of autoimmune diseases; SCT510 for the treatment of ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,277
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.